William Lis

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Bruce Blefeld, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William Lis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zai Lab Ltd Director American Depositary Shares 35.1K $1.25M $35.67 20 Jun 2025 Direct
Jasper Therapeutics, Inc. Director Voting Common Stock 53.5K $34.7K $0.65 13 Oct 2023 Direct
Jasper Therapeutics, Inc. Director Stock Option (right to buy) 47K 07 Jun 2023 Direct

Insider Reports Filed by William Lis

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZLAB Zai Lab Ltd 18 Jun 2025 2 -$493K 4 Director 23 Jun 2025, 16:10
ZLAB Zai Lab Ltd 28 Feb 2025 1 -$495K 4 Director 04 Mar 2025, 17:11
ZLAB Zai Lab Ltd 01 Jul 2024 2 -$180K 4 Director 03 Jul 2024, 14:04
ZLAB Zai Lab Ltd 18 Jun 2024 1 $0 4 Director 20 Jun 2024, 17:00
JSPR Jasper Therapeutics, Inc. 13 Oct 2023 1 -$6.78K 4 Director 13 Oct 2023, 18:56
ZLAB Zai Lab Ltd 29 Jun 2023 1 $500K 4 Director 30 Jun 2023, 16:05
JSPR Jasper Therapeutics, Inc. 07 Jun 2023 1 $0 4 Director 08 Jun 2023, 18:42
JSPR Jasper Therapeutics, Inc. 13 Apr 2023 1 -$12.2K 4 Director 14 Apr 2023, 16:14
ZLAB Zai Lab Ltd 03 Mar 2023 1 -$208K 4 Director 07 Mar 2023, 15:05
JSPR Jasper Therapeutics, Inc. 12 Oct 2022 1 $0 4 Director 13 Oct 2022, 19:58
JSPR Jasper Therapeutics, Inc. 24 Jun 2022 2 -$101K 4 Director 28 Jun 2022, 16:01
JSPR Jasper Therapeutics, Inc. 21 Mar 2022 4 $0 4 Executive Chairman of the Board, Director 23 Mar 2022, 18:01
ZLAB Zai Lab Ltd 20 Jan 2022 1 -$103K 4 Director 21 Jan 2022, 16:10
ZLAB Zai Lab Ltd 03 Jan 2022 1 $0 4 Director 04 Jan 2022, 20:12
ZLAB Zai Lab Ltd 31 Dec 2021 1 -$691K 5 Director 14 Feb 2022, 15:05
JSPR Jasper Therapeutics, Inc. 24 Sep 2021 0 $0 3 Chief Executive Officer, Director 01 Oct 2021, 16:08